&Partners’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Sell
4,030
-1,668
-29% -$113K ﹤0.01% 2183
2026
Q1
$428K Buy
5,698
+483
+9% +$39.6K ﹤0.01% 1784
2025
Q4
$408K Sell
5,215
-1,526
-23% -$124K ﹤0.01% 1748
2025
Q3
$572K Buy
6,741
+102
+2% +$8.17K ﹤0.01% 1377
2025
Q2
$519K Buy
6,639
+3,352
+102% +$247K ﹤0.01% 1338
2025
Q1
$236K Buy
3,287
+295
+10% +$24.8K ﹤0.01% 1541
2024
Q4
$266K Buy
+2,992
New +$267K ﹤0.01% 1398

Other funds holding USPH

&Partners's USPH Position: Q2 2026 in Review

&Partners reduced its US Physical Therapy (USPH) stake by 29% in Q2 2026, selling an estimated $113K and leaving 4,030 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #2183.

&Partners first reported a position in USPH in Q4 2024 and has held it in 7 quarters since. The position peaked at $572K in Q3 2025. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • &Partners held 4,030 shares of US Physical Therapy worth $277K as of Q2 2026.
  • &Partners sold 1,668 US Physical Therapy shares in Q2 2026, an estimated $113K.
  • US Physical Therapy made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2183 holding.
  • &Partners first reported a position in US Physical Therapy in Q4 2024 and has held it in 7 quarters since.
  • &Partners's US Physical Therapy position peaked at $572K in Q3 2025.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.